<code id='58D7EB0581'></code><style id='58D7EB0581'></style>
    • <acronym id='58D7EB0581'></acronym>
      <center id='58D7EB0581'><center id='58D7EB0581'><tfoot id='58D7EB0581'></tfoot></center><abbr id='58D7EB0581'><dir id='58D7EB0581'><tfoot id='58D7EB0581'></tfoot><noframes id='58D7EB0581'>

    • <optgroup id='58D7EB0581'><strike id='58D7EB0581'><sup id='58D7EB0581'></sup></strike><code id='58D7EB0581'></code></optgroup>
        1. <b id='58D7EB0581'><label id='58D7EB0581'><select id='58D7EB0581'><dt id='58D7EB0581'><span id='58D7EB0581'></span></dt></select></label></b><u id='58D7EB0581'></u>
          <i id='58D7EB0581'><strike id='58D7EB0581'><tt id='58D7EB0581'><pre id='58D7EB0581'></pre></tt></strike></i>

          hotspot

          hotspot

          author:explore    Page View:84259
          Blue nerve cell surrounded by red antibodies. -- health coverage from STAT
          Adobe

          Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression of an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

          The positive outcome — a 61% reduction in the risk of relapse compared to a placebo — achieved the main goal of a Phase 3 clinical trial designed to demonstrate Vyvgart’s benefit for patients with chronic inflammatory demyelinating polyneuropathy, or CIDP.

          advertisement

          “We hit the bullseye,” said Argenx CEO Tim Van Hauwermeiren.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          Sen. Bill Cassidy on how to lower drug prices
          Sen. Bill Cassidy on how to lower drug prices

          AdobeInthe1952Oscar-winningmovie“HighNoon,”GaryCooper’sfacewastenseandpainedashesingle-handedlyfaced

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          Pentagon will tighten controls on classified information after Discord leak

          1:38AviewofDepartmentofDefenseinPentagonArlington-Virginia,March14,2023.CelalGunes/AnadoluAgencyviaG